FIECON
Margarida de Novais is an experienced professional currently serving as an Associate in HEOR & Access at FIECON since October 2023. Prior to this role, Margarida worked as a Market Researcher at RONIN International from October 2022 to April 2023 and completed a Summer Internship in Accounting and Finance at Jerónimo Martins in July and August 2022. Margarida holds a Bachelor of Arts in Economics and Politics from Lancaster University, where studies were completed from October 2020 to July 2023, and a High School Diploma in Economics from Escola Secundária Sebastião e Silva, earned in June 2020.
This person is not in any offices
FIECON
FIECON was born out of the desire to make a difference in the world we live in – harnessing the power of health economics for the good of humanity. To date, we have donated over £900,000 to charitable causes. Our services: We provide services across the life cycle of a product and have worked in countries across the globe. Our key service areas comprise: • Outcomes Research • Economic Modelling • Health Technology Assessment • Value Communication • Pricing & Reimbursement Our products: We challenge the conventional and think outside the box to provide game-changing, innovative products that meet your commercial needs. Our products include: • FIECON Model Builder • FIECON Value Platform • FIECON Modelling Center powered by FIECON Model Builder Our vision is to use economics for the good of humanity. We do this by making a positive difference in the lives of our people, our clients, and our society. Our core values guide our day-to-day actions and make FIECON a great place to work: * Learn, Grow, and Flourish Together * Deliver Results and Delight Clients * Improve Lives and Build a Better World Our ultimate aspiration is to set the bar for how workplaces operate, and by 2030 we aim to achieve a number of goals: We want to test the hypothesis that you can maintain a great culture as you grow, achieving external certification through the Great Place to Work award. We want to show that we have affected millions of lives – 100M in fact – which we can quantify based on the drugs we take to market each year. We want to give back BIG both in terms of our time and donations – £10M since our founding is the first stake in the ground. We also want to demonstrate that we are meeting the highest standards for social responsibility by achieving B-Corp status. hello@fiecon.com
Industries
Employees
51-200